Loading company…
Shanghai Chenggeng Biotechnology develops precision microbiome transplantation solutions.
Shanghai Chenggeng Biotechnology develops a Precision Microbiome Transplantation Treatment Platform and works across microbiome health, diagnostics, therapy, drugs, and data. Founded in 2022, the company is based in Shanghai, China. In December 2025, it raised over CNY 100 million in Series A funding from Grand Flight Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in